ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

A prospective real-world study of the efficacy and safety of aducanumab in China: Focus on early-onset and autosomal dominant Alzheimer's disease.

Jinwen Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.